Myeloma is associated with features of metabolic syndrome
Matthew Streetly(King's College - North Carolina), Martin Crook(Rutherford Appleton Laboratory), Gillian R. Milner(University of Cape Town), Inas El‐Najjar(Guy's and St Thomas' NHS Foundation Trust), Stephen Schey(University College Hospital), M. Kazmi
Cited by 3
Related Papers
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
|Blood|2000|502
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
|Journal of Clinical Oncology|2004|315